SPOCK1 promotes the proliferation, migration and invasion of glioma cells through PI3K/AKT and Wnt/β-catenin signaling pathways
Open Access
- 20 April 2016
- journal article
- Published by Spandidos Publications in Oncology Reports
- Vol. 35 (6) , 3566-3576
Abstract
Sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1 (SPOCK1) has been reported to promote the growth and progression of various tumors. In this study, we focus on assessing the effect of SPOCK1 on proliferation, migration and invasion in glioma cells and elucidating its related mechanisms. The results of our present study demonstrated that overexpression of SPOCK1 promoted the proliferation and inhibited apoptosis in glioma cells. Additionally, overexpression of SPOCK1 promoted the migration and invasion potential of glioma cells. Moreover, we demonstrated that PI3K/AKT and Wnt/β-catenin signaling pathways were activated by SPOCK1 over-expression. SPOCK1 silencing has precisely the opposite effect. In conclusion, our study suggests that SPOCK1 promotes proliferation, migration and invasion in glioma cells by activating PI3K/AKT and Wnt/β-catenin pathways, which provides a potential theoretical basis for clinical treatment of glioma.Keywords
This publication has 36 references indexed in Scilit:
- Up-regulation of SPOCK1 induces epithelial–mesenchymal transition and promotes migration and invasion in esophageal squamous cell carcinomaJournal of Molecular Histology, 2015
- SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathwayMolecular Cancer, 2015
- SPOCK1 is a novel transforming growth factor-β target gene that regulates lung cancer cell epithelial-mesenchymal transitionBiochemical and Biophysical Research Communications, 2013
- SPOCK1 Is Regulated by CHD1L and Blocks Apoptosis and Promotes HCC Cell Invasiveness and Metastasis in MiceGastroenterology, 2013
- Diagnosis, treatment, and prognosis of gliomaNeurology, 2010
- Temozolomide Versus Procarbazine, Lomustine, and Vincristine in Recurrent High-Grade GliomaJournal of Clinical Oncology, 2010
- Optimizing chemotherapy and radiotherapy for anaplastic gliomaNature Reviews Clinical Oncology, 2010
- Chemokines and glioma: Invasion and moreJournal of Neuroimmunology, 2010
- GliaSite Brachytherapy for Treatment of Recurrent Malignant Gliomas: A Retrospective Multi-institutional AnalysisNeurosurgery, 2006
- Diagnosis and Treatment of Recurrent High-Grade AstrocytomaJournal of Clinical Oncology, 2006